These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks. Le Jeunne C; Gómez JP; Pradalier A; Titus i Albareda F; Joffroy A; Liaño H; Henry P; Lainez JM; Geraud G Eur Neurol; 1999 Jan; 41(1):37-43. PubMed ID: 9885327 [TBL] [Abstract][Full Text] [Related]
44. [Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study]. Stöckli HR; Sword A Praxis (Bern 1994); 2003 Feb; 92(9):379-89. PubMed ID: 12674591 [TBL] [Abstract][Full Text] [Related]
45. Double-blind study of naproxen vs placebo in the treatment of acute migraine attacks. Andersson PG; Hinge HH; Johansen O; Andersen CU; Lademann A; Gøtzsche PC Cephalalgia; 1989 Mar; 9(1):29-32. PubMed ID: 2650879 [TBL] [Abstract][Full Text] [Related]
46. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study. Geraud G; Compagnon A; Rossi A; Eur Neurol; 2002; 47(2):88-98. PubMed ID: 11844897 [TBL] [Abstract][Full Text] [Related]
47. Drug treatment of migraine: Part I. Acute therapy and drug-rebound headache. Moore KL; Noble SL Am Fam Physician; 1997 Nov; 56(8):2039-48, 2051-4. PubMed ID: 9390098 [TBL] [Abstract][Full Text] [Related]
48. [Methodology of clinical trials in migraine: a rating system]. Tzourio C; Massiou H; Bousser MG Pathol Biol (Paris); 1992 Apr; 40(4):361-6. PubMed ID: 1495821 [TBL] [Abstract][Full Text] [Related]
50. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study. Bell CF; Foley KA; Barlas S; Solomon G; Hu XH Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170 [TBL] [Abstract][Full Text] [Related]
51. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine. Sørensen PS; Hansen K; Olesen J Cephalalgia; 1986 Mar; 6(1):7-14. PubMed ID: 3516409 [TBL] [Abstract][Full Text] [Related]
55. Some comments on the use of statistics in the evaluation of drug trials in migraine. Amery WK; Hoing M; Debroye M; Dom F Neuroepidemiology; 1987; 6(4):220-7. PubMed ID: 3683717 [TBL] [Abstract][Full Text] [Related]
57. Migraine trials: crossover or parallel group? Lewis JA Neuroepidemiology; 1987; 6(4):198-208. PubMed ID: 3683714 [TBL] [Abstract][Full Text] [Related]
58. Endpoints to evaluate efficacy of symptomatic drugs in migraine: what do patients want? Pietrini U; De Luca M; Del Bene E Headache; 2002 Oct; 42(9):948-9. PubMed ID: 12390628 [No Abstract] [Full Text] [Related]